Skip to main content
. 2022 Feb 9;17(7):e202100735. doi: 10.1002/cmdc.202100735

Table 1.

σ1 and σ2 receptor affinity of synthesized piperidines and some lead and reference compounds.

graphic file with name CMDC-17-0-g014.jpg

Compd

R1

NR2

K i±SEM [nM] (n=3)

σ1 : σ2

σ1

σ2

selectivity

136

1,3‐dioxane[a]

NHCH2Ph

6.0±1.0

4200

14

237

tetrahydropyran[a]

NHCH2Ph

1.6±0.2

378

236

338

cyclohexane[a]

NHCH2Ph

0.61±0.1

49±31

80

4a

H

NHCH2Ph

165

372

2.3

4b

H

NH(CH2)3Ph

849

0 %[b]

13a

Ts

NHCH2Ph

57±21

763

13

13b

Ts

NH(CH2)3Ph

291±139

567

2

18a

CH3

NHCH2Ph

7.9±0.2

483

61

18b

CH2CH3

NHCH2Ph

129±38

131

1

19a

CH3

NH(CH2)3Ph

50±17

0 %[b]

>20

19b

CH2CH3

NH(CH2)3Ph

2400

334

0,14

20a

CH3

NHCH2C6H11

16±5

285

18

21a

CH3

N(CH3)CH2Ph

19±9

77±5

4

22a

CH3

graphic file with name CMDC-17-0-g006.jpg

27±11

1600

59

(+)‐pentazocine

5.4±0.5

haloperidol

6.6±0.9

125±33

19

di‐o‐tolylguanidine

71±7.9

54±8

0.76

[a] Structures of compounds 13 are shown in Figure 1. [b] For compounds with low affinity the inhibition (in %) of radioligand binding at a test compound concentration of 1 μM is given. The piperidines were tested as mixtures of cis‐ and trans‐configured diastereomers. cis : trans=60 : 40 to 85 : 15.